168 related articles for article (PubMed ID: 14736075)
1. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
Gascon GG;
J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
[TBL] [Abstract][Full Text] [Related]
2. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
[TBL] [Abstract][Full Text] [Related]
3. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.
Yalaz K; Anlar B; Oktem F; Aysun S; Ustacelebi S; Gurcay O; Gucuyener K; Renda Y
Neurology; 1992 Mar; 42(3 Pt 1):488-91. PubMed ID: 1372397
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis.
Aydin OF; Senbil N; Kuyucu N; Gürer YK
J Child Neurol; 2003 Feb; 18(2):104-8. PubMed ID: 12693776
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.
Anlar B; Yalaz K; Oktem F; Köse G
Neurology; 1997 Feb; 48(2):526-8. PubMed ID: 9040751
[TBL] [Abstract][Full Text] [Related]
6. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.
Gascon G; Yamani S; Crowell J; Stigsby B; Nester M; Kanaan I; Jallu A
Brain Dev; 1993; 15(5):346-55. PubMed ID: 7506498
[TBL] [Abstract][Full Text] [Related]
7. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report.
Han CY; Lin HF; Shin PY; Liu CK; Liu CS
Kaohsiung J Med Sci; 2003 Aug; 19(8):416-20. PubMed ID: 12962429
[TBL] [Abstract][Full Text] [Related]
8. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis.
DuRant RH; Dyken PR; Swift AV
J Pediatr; 1982 Aug; 101(2):288-93. PubMed ID: 6178812
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
Dyken PR; Swift A; DuRant RH
Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols.
Haspolat S; Anlar B; Köse G; Coskun M; Yegin O
J Child Neurol; 2001 Jun; 16(6):417-20. PubMed ID: 11417607
[TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis.
Gokcil Z; Odabasi Z; Demirkaya S; Eroglu E; Vural O
J Neurol Sci; 1999 Jan; 162(1):62-4. PubMed ID: 10064170
[TBL] [Abstract][Full Text] [Related]
12. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
Haddad FS; Risk WS
Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
[TBL] [Abstract][Full Text] [Related]
13. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
Nihei K; Kudo H; Abe T; Naito H; Suzuki S; Miyao M
No To Hattatsu; 1984 Jul; 16(4):262-70. PubMed ID: 6207848
[No Abstract] [Full Text] [Related]
14. The effect of inosiplex on the survival of subacute sclerosing panencephalitis.
DuRant RH; Dyken PR
Neurology; 1983 Aug; 33(8):1053-5. PubMed ID: 6192362
[TBL] [Abstract][Full Text] [Related]
15. Intraventricular administration of interferon and administration of methisoprinol by mouth in the treatment of adult-onset subacute sclerosing panencephalitis.
Harbord MG; Jones T; Hicks EP; Blumbergs PC
Med J Aust; 1988 May; 148(9):467-9, 473. PubMed ID: 2452337
[TBL] [Abstract][Full Text] [Related]
16. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.
Anlar B; Yalaz K; Imir T; Turanli G
Eur Neurol; 1994; 34(1):44-7. PubMed ID: 7511102
[TBL] [Abstract][Full Text] [Related]
17. [Trial of intraventricular ribavirin and interferon-alpha combination therapy for subacute sclerosing panencephalitis (SSPE) in Japan].
Tomoda A; Nomura K; Shiraishi S; Miike T; Hamada A; Hosoya M
No To Hattatsu; 2003 Jul; 35(4):321-6. PubMed ID: 12875209
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
[TBL] [Abstract][Full Text] [Related]
19. Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis.
Gürer YK; Kükner S; Sarica B
Pediatr Neurol; 1996 Jan; 14(1):72-4. PubMed ID: 8652024
[TBL] [Abstract][Full Text] [Related]
20. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis.
Anlar B; Yalaz K; Köse G; Saygi S
J Child Neurol; 1998 Nov; 13(11):557-9. PubMed ID: 9853649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
